ActivityHealthcareBiotechDeal · IPO14 October 2026 · ClosedIambic Therapeutics raises $150 million in IPOIambic Therapeutics Issuer
Novo Nordisk reports 25% average weight loss for CagriSema in women in a new analysisNovo Nordisk·Pharma·20 Oct·CNBC
OpenAI acquires Orchestra Bio to add its team to the Rosalind life sciences modelDeal · AcquisitionOpenAI, Orchestra Bio, +1·AI·20 Oct·TechCrunch